Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ESWL on Disintegration of Renal Stones

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03939325
Recruitment Status : Unknown
Verified May 2019 by Mohamed Ahmed Mohamed El Taher, Assiut University.
Recruitment status was:  Not yet recruiting
First Posted : May 6, 2019
Last Update Posted : May 6, 2019
Sponsor:
Information provided by (Responsible Party):
Mohamed Ahmed Mohamed El Taher, Assiut University

Brief Summary:
The impact of different frequencies on pattern of disintegration of renal stones

Condition or disease Intervention/treatment
Renal Stone Radiation: ESWL

Detailed Description:
  • Prior to the introduction of extracorporeal shockwave lithotripsy (ESWL) in 1980, the only treatment available for calculi that could not pass through the urinary tract was open surgery. Since then, ESWL has become the preferred tool in the urologist's armamentarium for the treatment of renal stones, , ESWL is minimally invasive, exposes patients to less anaesthesia, and yields equivalent stone-free rates in appropriately selected patients.
  • The efficacy of ESWL lies in its ability to pulverize calculi in vivo into smaller fragments, which the body can then expulse spontaneously. Shockwaves are generated and then focused onto a point within the body. The shockwaves propagate through the body with negligible dissipation of energy (and therefore damage) owing to the minimal difference in density of the soft tissues. At the stone-fluid interface, the relatively large difference in density, coupled with the concentration of multiple shockwaves in a small area, produces a large dissipation of energy. Via various mechanisms, this energy is then able to overcome the tensile strength of the calculi, leading to fragmentation. Repetition of this process eventually leads to pulverization of the calculi into small fragments that the body can pass spontaneously and painlessly.
  • It is well recognized that the popularity of extracorporeal shock wave lithotripsy (SWL), despite its non-invasive character, has decreased during recent years. This is partly explained by the technological achievements in endoscopy and urologists' enthusiasm for such procedures. Another explanation is that many urologists have been insufficiently successful with SWL. The latter effect might to some extent be a result of the performance of the lithotripter used, but in too many cases, it is evident that the principles of how shock wave lithotripsy should be carried out are poorly appliedical aspect

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 90 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 2 Weeks
Official Title: Impact of Different Shock Wave Release Frequencies on Disintegration of Renal Stones in Assuit Urology & Nephrology University Hospital
Estimated Study Start Date : May 5, 2019
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Stones

Group/Cohort Intervention/treatment
first group
patient who exposed to frequency 60 shock wave per min
Radiation: ESWL
The impact of different frequencies on pattern of disintegration of renal stones

second group
patient who exposed to frequency 80 shock wave per min
Radiation: ESWL
The impact of different frequencies on pattern of disintegration of renal stones

third group
patient who exposed to frequency 100 shock wave per min
Radiation: ESWL
The impact of different frequencies on pattern of disintegration of renal stones




Primary Outcome Measures :
  1. stone free rate [ Time Frame: 2 weeks ]
    complete disintegration of renal stones or having clinically insignificant gravel smaller than 2 mm



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients were recruited from the outpatient clinic from age 18 years to 70 years old with renal stone who candidate for ESWL
Criteria

Inclusion Criteria:

  • Pelvic and upper ureteric stones
  • Stone size less than 2 cm
  • Stone density up to 1000 HU

Exclusion Criteria:

  • Lower calycle stone
  • Stone size 2 cm or more
  • Stone denstiy more than 1000
  • age group less than 18 y
  • uncontrolled hypertension patient and bleeding disorder
  • Pregnancy
  • Patients with UPJ obstruction, ureteral strictures,
  • Congenital anomalies
  • Previous stented ureter
  • Narrow neck of the calycx less than 30 %

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03939325


Contacts
Layout table for location contacts
Contact: Mohamed A EL Taher 01127204629 mohamed_el_taher7392@yahoo.com
Contact: Ahmed M Reda 01005096801 ahmed_leo@yahh.com

Sponsors and Collaborators
Assiut University
Publications:
Layout table for additonal information
Responsible Party: Mohamed Ahmed Mohamed El Taher, M.B.B.CH, Assiut University
ClinicalTrials.gov Identifier: NCT03939325    
Other Study ID Numbers: impact of ESWL in Renal Stones
First Posted: May 6, 2019    Key Record Dates
Last Update Posted: May 6, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Calculi
Nephrolithiasis
Calculi
Pathological Conditions, Anatomical
Kidney Diseases
Urologic Diseases
Urolithiasis
Urinary Calculi